ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0193

Patients with Asthma Have a Higher Risk of Rheumatoid Arthritis: A Systematic Review and Meta-analysis

Nipith Charoenngam1, Ben Ponvilawan1, Thanitsara Rittiphairoj1, Surapa Tornsatitkul1, Phuuwadith Wattanachayakul1, Pongprueth Rujirachun1 and Patompong Ungprasert2, 1Mahidol University, Bangkok, Thailand, 2Cleveland Clinic, Cleveland, OH, Cleveland Heights, OH

Meeting: ACR Convergence 2020

Keywords: Epidemiology, rheumatoid arthritis, risk factors

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Multimorbidity

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Studies have reported the association between asthma and elevated risk of several chronic diseases, such as inflammatory bowel disease, diabetes mellitus and coronary heart disease. Additionally, there are data on the association between asthma and risk of rheumatoid arthritis (RA), although the results from existing studies are largely inconsistent. The current systematic review and meta-analysis was conducted in order to investigate whether patients with asthma have an increased risk of rheumatoid arthritis by identifying all available studies and summarizing their results together.

Methods: Potentially eligible studies were identified from Medline and EMBASE databases from inception to November 2019 using search strategy that comprised of terms for “Asthma” and “Rheumatoid arthritis”. Eligible cohort study must consist of one cohort of patients with asthma and another cohort of individuals without asthma. Then, the study must report relative risk (RR) with 95% confidence intervals (95% CIs) comparing incident RA between the groups. Eligible case-control studies must include cases with RA and controls without RA.  Then, the study must explore their history of asthma. Odds ratio (OR) with 95% CIs of the association between RA and prior history of asthma must be reported. Point estimates with standard errors were retrieved from each study and were combined together using the generic inverse variance method of DerSimonian and Laird.

Results: A total of 21,824 articles were identified. After two rounds of independent review by three investigators, 5 cohort studies and 11 case-control studies met the eligibility criteria and were included into the meta-analysis. Patients with asthma had a significantly higher risk of incident RA compared with individuals without asthma with the pooled RR of 1.48 (95% CI, 1.20 – 1.82; I2 92%).

Conclusion: This systematic review and meta-analysis found a significant association between asthma and a higher risk of incident RA.

Figure 1: Forest plot of the meta-analysis of risk of RA in individuals with asthma versus individuals without asthma


Disclosure: N. Charoenngam, None; B. Ponvilawan, None; T. Rittiphairoj, None; S. Tornsatitkul, None; P. Wattanachayakul, None; P. Rujirachun, None; P. Ungprasert, None.

To cite this abstract in AMA style:

Charoenngam N, Ponvilawan B, Rittiphairoj T, Tornsatitkul S, Wattanachayakul P, Rujirachun P, Ungprasert P. Patients with Asthma Have a Higher Risk of Rheumatoid Arthritis: A Systematic Review and Meta-analysis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/patients-with-asthma-have-a-higher-risk-of-rheumatoid-arthritis-a-systematic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-with-asthma-have-a-higher-risk-of-rheumatoid-arthritis-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology